Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers.
Chen F, Chandrashekar DS, Varambally S, Creighton CJ. · 2019
Read Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. by Chen F, Chandrashekar DS, Varambally S, Creighton CJ. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6908580.txt.
Description
Chen and co-authors sort cancers by protein rather than by organ, in Nature Communications. Cancer classification usually follows the tissue where a tumour began. Gene activity studies have added molecular subtypes. Proteins, the molecules that do the work, may draw a sharper map. The team profiled cancers with mass spectrometry, a method that weighs and identifies proteins directly.
Across 532 cancers spanning breast, colon, ovarian, renal, and uterine types, the protein data formed ten pan-cancer subtypes. The groups cut across tissue lineages and appeared again in outside datasets. Two subtypes centred on the immune system, one on adaptive T cell responses and one on antibody-style responses. Pathway signatures separated the groups further.
Catalog record
| CREATOR | Chen F, Chandrashekar DS, Varambally S, Creighton CJ. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |